First Annual National Lymphoma Awareness Week

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 5 No 9
Volume 5
Issue 9

LOS ANGELES, Calif--The first annual National Lymphoma Awareness Week, sponsored by the Lymphoma Research Foundation of America, is scheduled for October 13 to 19. Members of the Foundation will launch local awareness activities and educational events throughout the week to inform the public about lymphatic cancers.

LOS ANGELES, Calif--The first annual National Lymphoma AwarenessWeek, sponsored by the Lymphoma Research Foundation of America,is scheduled for October 13 to 19. Members of the Foundation willlaunch local awareness activities and educational events throughoutthe week to inform the public about lymphatic cancers.

Actress Jamie Lee Curtis serves as Honorary Chair for AwarenessWeek. Actress Tracy Nelson, daughter of the late singer Rick Nelson,is a Hodgkin's lymphoma survivor and acts as spokesperson forthe Lymphoma Research Foundation. Both actresses have recordeda series of informative public service radio announcements aboutthe disease.

The Lymphoma Research Foundation of America was organized in 1991to raise funds to support research projects seeking to cure lymphomaand find better, safer treatments. To date, 32 research grantshave been awarded.

Internet Site

The Lymphoma Research Foundation also sponsors lymphoma supportgroups, provides programs and resource referrals for patients,publishes a newsletter, and maintains an informative site on theInternet that can be reached at: http://www.lymphoma.org.

Recent Videos
The approval of daratumumab validates the notion of using limited therapy to help delay progression from smoldering disease to multiple myeloma.
According to Aditya Bardia, MD, MPH, FASCO, antibody-drug conjugates are slowly replacing chemotherapy as a standard treatment for breast cancer.
A simulation procedure helped to ascertain chemotherapy tolerability before administering radioembolization therapy for NETs with liver metastases.
The addition of radioembolization to radiosensitizing chemotherapy may help concurrently treat patients with liver tumors and disease outside the liver.
In neuroendocrine tumor management, patients with insulinoma may be at risk of severe hypoglycemia following receipt of GLP-1 receptor agonists.
Decreasing the low-dose bath of proton therapy to the body may limit the impact of radiation on lymphocytes and affect tumor response.
4 experts are featured in this series.
4 experts are featured in this series.
According to Eyub Akdemir, MD, reducing EDIC may be feasible without compromising target coverage to reduce anticipated lymphopenia rates.
7 experts are featured in this series.
Related Content